Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode

Am J Med Genet. 1996 Jul 26;67(4):406-8. doi: 10.1002/(SICI)1096-8628(19960726)67:4<406::AID-AJMG15>3.0.CO;2-N.

Abstract

To investigate the possible role of the dopamine transporter (DAT) gene in determining the phenotype in human subjects, allele frequencies for the 40-bp variable number of tandem repeats (VNTR) polymorphism at this site were compared between 117 Japanese normal controls and 118 schizophrenic patients, including six subgroups: early-onset, those with a family history, and those suffering from one of the following psychiatric symptoms at their first episode: delusion and hallucination; disorganization; bizarre behavior; and negative symptoms. No significant differences were observed between the group as a whole or any subgroup of schizophrenic patients and controls. The results indicate that VNTR polymorphism in the DAT gene is unlikely to be a major contributor to any of the psychiatric parameters examined in the present population of schizophrenic subjects.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Carrier Proteins / genetics*
  • DNA / blood
  • Delusions
  • Dopamine Plasma Membrane Transport Proteins
  • Female
  • Gene Frequency
  • Hallucinations
  • Humans
  • Japan
  • Male
  • Membrane Glycoproteins*
  • Membrane Transport Proteins*
  • Middle Aged
  • Minisatellite Repeats*
  • Nerve Tissue Proteins*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Reference Values
  • Schizophrenia / genetics*
  • Schizophrenia, Paranoid / genetics
  • Schizophrenic Psychology

Substances

  • Carrier Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A3 protein, human
  • DNA